newsfilter
← Latest News
PR Newswire·

Lipocine Announces LPCN 2101 Abstracts Accepted for Presentation at AES 2025

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with...